Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (391-400 of 645) with videos related to

Pageof 65
Sort By:
Respiratory Medicine|March 16, 2013
Chronic treatment with indacaterol and airway response to salbutamol in stable COPDMario Cazzola, Paola Rogliani, Paolo Ruggeri, et al.
Respiratory Medicine|May 25, 2013
Asthma and COPD in an Italian adult population: role of BMI considering the smoking habitMario Cazzola, Luigino Calzetta, Davide Lauro, et al.
Pulmonary Pharmacology & Therapeutics|January 3, 2018
Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot studyPaola Rogliani, Josuel Ora, Ermanno Puxeddu, et al.
Respiratory Medicine|August 23, 2011
Cardiovascular disease in asthma and COPD: a population-based retrospective cross-sectional studyMario Cazzola, Luigino Calzetta, Germano Bettoncelli, et al.
Drugs|March 29, 2017
Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular DiseasesMario Cazzola, Luigino Calzetta, Barbara Rinaldi, et al.
Pulmonary Pharmacology & Therapeutics|April 3, 2018
Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysisPaola Rogliani, Maria Gabriella Matera, Ermanno Puxeddu, et al.
Respiratory Medicine|October 23, 2012
Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterolMario Cazzola, Andrea Segreti, Emanuele Stirpe, et al.
Drugs|September 26, 2024
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological InterferencesMario Cazzola, Clive P Page, Nicola A Hanania, et al.
Respiratory Research|July 30, 2023
Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPDMario Cazzola, Clive P Page, Jadwiga A Wedzicha, et al.
Expert Opinion on Pharmacotherapy|February 2, 2019
Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary diseasePaola Rogliani, Luigino Calzetta, Maria Gabriella Matera, et al.
Pageof 65

Showing results (391-400 of 645) with videos related to

Sort By:
Pageof 65
Respiratory Medicine|March 16, 2013
Chronic treatment with indacaterol and airway response to salbutamol in stable COPDMario Cazzola, Paola Rogliani, Paolo Ruggeri, et al.
Respiratory Medicine|May 25, 2013
Asthma and COPD in an Italian adult population: role of BMI considering the smoking habitMario Cazzola, Luigino Calzetta, Davide Lauro, et al.
Pulmonary Pharmacology & Therapeutics|January 3, 2018
Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot studyPaola Rogliani, Josuel Ora, Ermanno Puxeddu, et al.
Respiratory Medicine|August 23, 2011
Cardiovascular disease in asthma and COPD: a population-based retrospective cross-sectional studyMario Cazzola, Luigino Calzetta, Germano Bettoncelli, et al.
Drugs|March 29, 2017
Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular DiseasesMario Cazzola, Luigino Calzetta, Barbara Rinaldi, et al.
Pulmonary Pharmacology & Therapeutics|April 3, 2018
Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysisPaola Rogliani, Maria Gabriella Matera, Ermanno Puxeddu, et al.
Respiratory Medicine|October 23, 2012
Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterolMario Cazzola, Andrea Segreti, Emanuele Stirpe, et al.
Drugs|September 26, 2024
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological InterferencesMario Cazzola, Clive P Page, Nicola A Hanania, et al.
Respiratory Research|July 30, 2023
Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPDMario Cazzola, Clive P Page, Jadwiga A Wedzicha, et al.
Expert Opinion on Pharmacotherapy|February 2, 2019
Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary diseasePaola Rogliani, Luigino Calzetta, Maria Gabriella Matera, et al.
Pageof 65